Cargando…
The effectiveness of different singly administered high doses of buprenorphine in reducing suicidal ideation in acutely depressed people with co-morbid opiate dependence: a randomized, double-blind, clinical trial
BACKGROUND: Buprenorphine is usually administered to treat opioid use disorder and pain syndromes. This research presents the first study regarding the effectiveness of different singly administered high doses of buprenorphine (a partial opioid agonist (of μ-opioid receptors), a potent opioid antago...
Autores principales: | Ahmadi, Jamshid, Jahromi, Mina Sefidfard, Ehsaei, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114789/ https://www.ncbi.nlm.nih.gov/pubmed/30157924 http://dx.doi.org/10.1186/s13063-018-2843-9 |
Ejemplares similares
-
Rapid effect of a single-dose buprenorphine on reduction of opioid craving and suicidal ideation: A randomized, double blind, placebo-controlled study
por: Ahmadi, Jamshid, et al.
Publicado: (2019) -
Anxiety Treatment of Opioid Dependent Patients with Buprenorphine: A Randomized, Double-blind, Clinical Trial
por: Ahmadi, Jamshid, et al.
Publicado: (2017) -
Single high-dose buprenorphine for opioid craving during withdrawal
por: Ahmadi, Jamshid, et al.
Publicado: (2018) -
Anxiety treatment of methamphetamine-dependent patients with buprenorphine: A randomized, double-blind, clinical trial
por: Ahmadi, Jamshid, et al.
Publicado: (2022) -
Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial
por: Ahmadi, Jamshid, et al.
Publicado: (2017)